GGrantIndex
← Search

OBl-1 301:Pivotal study, congential hemophilia, all bleeding categories

$0R44FY2005HLNIH

Octagen Corporation, Blue Bell PA

Investigators

View original record on NIH RePORTER →
OBl-1 301:Pivotal study, congential hemophilia, all bleeding categories · GrantIndex